Philip Huxley

Company: Bicycle Therapeutics

Job title: Vice President, Oncology

Seminars:

Harnessing and Evaluating the Use of Bicycle Toxin Conjugates in Place of Traditional ADCs to Reduce Toxicities 2:15 pm

Exploring the use of bicycle peptides as an alternative to antibodies for the delivery of cytotoxic payloads to reduce toxicities Comparison of the toxicity profile of BTCs with standard ADCs Exploring physiochemical properties to reduce off target toxicityRead more

day: Conference Day 2